(WMD:Stuttgart Stock Exchange)
Cheryl L. Cohen
Former Chief Commercial Officer, Medivation, Inc.
|Age||Total Calculated Compensation||This person is connected to 33 board members in 2 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Ms. Cheryl L. Cohen served as the Chief Commercial Officer of Medivation, Inc. from September 2, 2011 to July 10, 2014 and served as its Head of Marketing. Ms. Cohen was responsible for the Medivation's U.S. launch of Xtandi (enzalutamide) for metastatic castration-resistant prostate cancer. Prior to joining Medivation, Ms. Cohen served as the President of CLC Consulting, a pharmaceutical and biotechnology consulting firm specializing in new product start-up and commercialization ...
525 Market StreetPhone: 415-543-3470
San Francisco, California 94105
Board Members Memberships*
St Joseph College
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|